Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 3/2012

01.03.2012 | Gynecologic Oncology

Prevalence and risk factors of HPV infection among women from various provinces of the world

verfasst von: Krishnakumar Vinodhini, Santhanam Shanmughapriya, Bhudev C. Das, Kalimuthusamy Natarajaseenivasan

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Objective

We set to estimate the genotype-specific prevalence of human papilloma virus (HPV) and its associated risk factors responsible among women with normal and abnormal cytology by systematic literature survey.

Methods

Reports on HPV prevalence published between 2000 and 2011 were retrieved. To be included, studies required information on cervical cytology, plus detailed descriptions of study populations, methods used to collect cervical samples, and assays used for HPV DNA detection and typing. Final analyses included 280 studies of which 120 were included in the final analysis. The OR, 95% CI and P value were calculated using SPSS 16.0.

Results

Overall HPV prevalence in 576,281 women was estimated to be 32.1% (95% CI 32.098, 32.102). Corresponding estimates by region showed Eastern Asia (China) with the highest prevalence of about 57.7% of the HPV infection followed by South Central Asia (Indian subcontinent). The HPV prevalence was higher in less developed countries (42.2%) than in more developed regions (22.6%). The type-specific HPV prevalence study showed HPV 16 (9.5%) and 18 (6.2%) to be the prevalent type irrespective of the region of study. First coitus at a younger (≤15) age, increased number of pregnancies, increased number of sexual partners, use of contraceptives, smoking and chewing habit and early age at marriage were recognized as the significant risk factors for HPV infection. The phylogenetic analysis of HPV-16 showed the clustering of Indian sequence with the European and American sequences suggesting a similarity between HPV types. Even though the oncogenic proteins of HPV-16 detected in more developed and less developed regions clustered, the prevalence and the severity of the diseases among the less developed regions could be well explained as the exposure of the population to the possible associated risk factors concerning to the living conditions and nature of the life style adopted by the population.
Literatur
1.
Zurück zum Zitat Curado MP, Edwards B, Shin HR et al (eds) (2007) Cancer incidence in five continents. In: IARC Scientific Publications, 9th edn. International Agency for Research on Cancer, Lyon, France Curado MP, Edwards B, Shin HR et al (eds) (2007) Cancer incidence in five continents. In: IARC Scientific Publications, 9th edn. International Agency for Research on Cancer, Lyon, France
2.
Zurück zum Zitat Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int J Cancer 80:827–841PubMedCrossRef Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int J Cancer 80:827–841PubMedCrossRef
3.
Zurück zum Zitat Parkin DM, Pisani P, Ferlay J (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594–606PubMedCrossRef Parkin DM, Pisani P, Ferlay J (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594–606PubMedCrossRef
4.
Zurück zum Zitat Ferlay J, Parkin DM, Pisani P (1998) GLOBOCAN 1: cancer incidence and mortality worldwide. IARC Cancer Base no 3. IARC Press, Lyon Ferlay J, Parkin DM, Pisani P (1998) GLOBOCAN 1: cancer incidence and mortality worldwide. IARC Cancer Base no 3. IARC Press, Lyon
5.
Zurück zum Zitat Walboomers JM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19PubMedCrossRef Walboomers JM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19PubMedCrossRef
6.
Zurück zum Zitat de Sanjose S, Diaz M, Castellsague X et al (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7:453–459PubMedCrossRef de Sanjose S, Diaz M, Castellsague X et al (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7:453–459PubMedCrossRef
7.
Zurück zum Zitat Centers for disease control and prevention (2007) Epidemiology and prevention of vaccine-preventable diseases, 10th edn. Public Health Foundation, Washington Centers for disease control and prevention (2007) Epidemiology and prevention of vaccine-preventable diseases, 10th edn. Public Health Foundation, Washington
8.
Zurück zum Zitat Ostor AG (1993) Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 12(2):186–192PubMedCrossRef Ostor AG (1993) Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 12(2):186–192PubMedCrossRef
9.
Zurück zum Zitat Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase 2.0 edn. IARC Press, Lyon Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase 2.0 edn. IARC Press, Lyon
10.
Zurück zum Zitat Li LK, Dai M, Clifford GM et al (2006) Human papilloma virus infection in Shenyang City, People’s Republic of China: a population-based study. Br J Cancer 95:37–1593CrossRef Li LK, Dai M, Clifford GM et al (2006) Human papilloma virus infection in Shenyang City, People’s Republic of China: a population-based study. Br J Cancer 95:37–1593CrossRef
11.
Zurück zum Zitat Wen-ying Zhang, Yue-zhen Xue et al (2008) Prevalence of high-risk human papillomavirus infection in different cervical lesion among organized health-examination women in Shanghai, China. Chin Med J 121:1578–1582 Wen-ying Zhang, Yue-zhen Xue et al (2008) Prevalence of high-risk human papillomavirus infection in different cervical lesion among organized health-examination women in Shanghai, China. Chin Med J 121:1578–1582
12.
Zurück zum Zitat Liu J, Rose B, Huang X et al (2004) Comparative analysis of characteristics of women with cervical cancer in high- versus low incidence regions. Gynecol Oncol 94:803–810PubMedCrossRef Liu J, Rose B, Huang X et al (2004) Comparative analysis of characteristics of women with cervical cancer in high- versus low incidence regions. Gynecol Oncol 94:803–810PubMedCrossRef
13.
Zurück zum Zitat Anon (2005) UNAIDS: global AIDS epidemic just beginning. AIDS Policy Law 20:1 Anon (2005) UNAIDS: global AIDS epidemic just beginning. AIDS Policy Law 20:1
14.
Zurück zum Zitat Currin LG, Jack RH, Linklater KM et al (2009) Inequalities in the incidence of cervical cancer in South East England 2001–2005: an investigation of population risk factors. BMC Public Health 9. doi:10.1186/1471-2458-9-62 Currin LG, Jack RH, Linklater KM et al (2009) Inequalities in the incidence of cervical cancer in South East England 2001–2005: an investigation of population risk factors. BMC Public Health 9. doi:10.​1186/​1471-2458-9-62
15.
Zurück zum Zitat Moreno V, Bosch FX, Munoz N et al (2002) Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 30:1085–1092CrossRef Moreno V, Bosch FX, Munoz N et al (2002) Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 30:1085–1092CrossRef
16.
Zurück zum Zitat Ragin CC,Watt RA,Markovic N et al (2009) Comparisons of high-risk cervical HPV infections in Caribbean and US populations. Infect Agent Cancer 4. doi:10.1186/1750-9378-4-S1-S9 Ragin CC,Watt RA,Markovic N et al (2009) Comparisons of high-risk cervical HPV infections in Caribbean and US populations. Infect Agent Cancer 4. doi:10.​1186/​1750-9378-4-S1-S9
17.
Zurück zum Zitat Thomas JO, Herrero R, Omigbodun AA et al (2004) Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 90:638–645PubMedCrossRef Thomas JO, Herrero R, Omigbodun AA et al (2004) Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 90:638–645PubMedCrossRef
18.
Zurück zum Zitat Bhatla N, Lal N, Bao YP et al (2008) A meta analysis of human papillomavirus type-distribution in women from south Asia: implications for vaccination. Vaccine 26:2811–2817PubMedCrossRef Bhatla N, Lal N, Bao YP et al (2008) A meta analysis of human papillomavirus type-distribution in women from south Asia: implications for vaccination. Vaccine 26:2811–2817PubMedCrossRef
19.
Zurück zum Zitat Bayo S, Bosch FX, Sanjose DS et al (2002) Risk factors of invasive cervical cancer in Mali. Int J Epidemiol 31:202–209PubMedCrossRef Bayo S, Bosch FX, Sanjose DS et al (2002) Risk factors of invasive cervical cancer in Mali. Int J Epidemiol 31:202–209PubMedCrossRef
20.
Zurück zum Zitat Hildesheim A, Wang SS (2002) Host and viral genetics and risk of cervical cancer: a review. Virus Res 89:229–240PubMedCrossRef Hildesheim A, Wang SS (2002) Host and viral genetics and risk of cervical cancer: a review. Virus Res 89:229–240PubMedCrossRef
21.
Zurück zum Zitat Strickler HD, Palefsky JM, Shah KV et al (2003) Human papillomavirus type 16 and immune status in human immunodeficiency virus seropositive women. J Natl Cancer Inst 95:1062–1071PubMedCrossRef Strickler HD, Palefsky JM, Shah KV et al (2003) Human papillomavirus type 16 and immune status in human immunodeficiency virus seropositive women. J Natl Cancer Inst 95:1062–1071PubMedCrossRef
22.
Zurück zum Zitat Clifford G, Gallus S, Herrero R et al (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366:991–998PubMedCrossRef Clifford G, Gallus S, Herrero R et al (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366:991–998PubMedCrossRef
23.
Zurück zum Zitat Biswas C, Kell B, Mant C et al (1997) Detection of human papillomavirus type 16 early-gene transcription by reverse transcription-PCR is associated with abnormal cervical cytology. J Clin Microbiol 35:1560–1564PubMed Biswas C, Kell B, Mant C et al (1997) Detection of human papillomavirus type 16 early-gene transcription by reverse transcription-PCR is associated with abnormal cervical cytology. J Clin Microbiol 35:1560–1564PubMed
24.
Zurück zum Zitat Parkin DM, Pisani P, Ferlay J et al (1999) Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int J Cancer 80:827–841PubMedCrossRef Parkin DM, Pisani P, Ferlay J et al (1999) Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int J Cancer 80:827–841PubMedCrossRef
25.
Zurück zum Zitat Balaram P, Sridhar H, Rajkumar T et al (2002) Oral cancer in Southern India: the influence of smoking, drinking, paan-chewing and oral hygiene. Int J Cancer 98:440–444PubMedCrossRef Balaram P, Sridhar H, Rajkumar T et al (2002) Oral cancer in Southern India: the influence of smoking, drinking, paan-chewing and oral hygiene. Int J Cancer 98:440–444PubMedCrossRef
26.
Zurück zum Zitat Szarewski A, Cuzick J et al (1998) Smoking and cervical neoplasia: a review of the evidence. J Epidemiol Biostat 3:229–256 Szarewski A, Cuzick J et al (1998) Smoking and cervical neoplasia: a review of the evidence. J Epidemiol Biostat 3:229–256
Metadaten
Titel
Prevalence and risk factors of HPV infection among women from various provinces of the world
verfasst von
Krishnakumar Vinodhini
Santhanam Shanmughapriya
Bhudev C. Das
Kalimuthusamy Natarajaseenivasan
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 3/2012
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-011-2155-8

Weitere Artikel der Ausgabe 3/2012

Archives of Gynecology and Obstetrics 3/2012 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.